Clinical Trial Update: Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909 [Phase 1]

View source ↗

Summary

Phase 1 trial from University of Oxford reports safety and immunogenicity data for malaria vaccines AdCh63 AMA1, MVA AMA1, and AMA1-C1/Alhydrogel with or withou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AMA1-C1/Alhydrogel +/- CPG 7909
• AdCh63 AMA1 (Chimpanzee adenovirus ChAd63 vector expressing AMA1)
• MVA AMA1 (Modified vaccinia Ankara expressing AMA1)

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1 | Status: COMPLETED